Study suggests changing HNSCC treatment for anaemic patients

A long-term analysis of a head and neck squamous cell carcinoma (HNSCC) study had surprising results, finding that practitioners who treat HNSCC patients who are also anaemic should not add erthyropoietin to the patient’s radiotherapy or chemotherapy care.

Dr Bicuspid